SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MJ who wrote (2607)7/16/1998 8:25:00 AM
From: Brian Moloney  Read Replies (3) of 3725
 
Actually the controversy about stress tests is one of the things that is polarizing the medical community. Stress tests will not be gone; their niche will be in a different place. The Heart-Lung Institute's study should go a long way toward developing a protocol to determine who would benefit from EBCT and who would benefit from a treadmill. Many of my patients get a treadmill after their scan. The marketing approach should be that by the time a stress test is positive, it is time for some sort of invasive intervention. Ultrafast can detect disease long before one gets that far down the road.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News